Hanyang Liu

Hanyang Liu is a research scientist specializing in in vivo pharmacology with a focus on cancer treatments, currently employed at Takeda Oncology since July 2022. Previous roles include serving as an associate scientist in immuno-oncology at Takeda and as a research associate at SQZ Biotechnologies, where efforts concentrated on murine autoimmune disease models to evaluate cell therapies. Hanyang also has experience as a biological engineer at Bio-Tree Systems Inc., conducting preclinical drug efficacy studies, and as a graduate student at Brown University, with a research emphasis on antimicrobial coating development. Hanyang holds a Master of Science in Biomedical/Medical Engineering from Brown University and a Bachelor of Science in the same field from the University of Rochester. Additionally, Hanyang participated in a program at Harvard Medical School in 2022.